Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"Myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) are serious, debilitating conditions that affect millions of people in the United States and around the world. ME/CFS can cause significant impairment and disability. Despite substantial efforts by researchers to better understand ME/CFS, there is no known cause or effective treatment. Diagnosing the disease remains a challenge, and patients often struggle with their illness for years before an identification is made. Some health care providers have been skeptical about the serious physiological - rather than psychological - nature of the illness. Once diagnosed, patients often complain of receiving hostility from their health care provider as well as being subjected to treatment strategies that exacerbate their symptoms. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome proposes new diagnostic clinical criteria for ME/CFS and a new term for the illness - systemic exertion intolerance disease(SEID). According to this report, the term myalgic encephalomyelitis does not accurately describe this illness, and the term chronic fatigue syndrome can result in trivialization and stigmatization for patients afflicted with this illness. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome stresses that SEID is a medical - not a psychiatric or psychological - illness. This report lists the major symptoms of SEID and recommends a diagnostic process.One of the report's most important conclusions is that a thorough history, physical examination, and targeted work-up are necessary and often sufficient for diagnosis. The new criteria will allow a large percentage of undiagnosed patients to receive an accurate diagnosis and appropriate care. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome will be a valuable resource to promote the prompt diagnosis of patients with this complex, multisystem, and often devastating disorder; enhance public understanding; and provide a firm foundation for future improvements in diagnosis and treatment."--

Myalgic encephalomyelitis --- Chronic fatigue syndrome --- Diagnosis.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"ME/CFS: Causes, Clinical Features and Diagnosis" addresses the early stages of ME/CFS and underlying predisposing factors. It considers the plight of the individual patient, and also the impact of the illness on society as a whole, which is considerable, in terms of both costs and social disruption. Patients and their families and carers frequently experience discrimination and difficulties accessing care. This volume will be of particular interest to those undertaking scientific research and those providing clinical care for ME/CFS patients, as well as to social policy analysts, policy makers and governments, and specialists in social research and medical education. There is a major focus on shortcomings in terms of medical education, resulting in considerable gaps in knowledge and understanding of the condition among many doctors. International comparisons indicate that these problems are encountered in many countries. This is particularly topical at a time when Long Covid-19 has moved post-viral syndromes to the forefront of the political agenda, and confronted society with new challenges in this area on a hitherto unprecedented scale. The volume addresses the many points of similarity between Long Covid-19 and ME/CFS. Mitigation of the illness is also addressed, through espousal of a more patient-centred approach to care, and through consideration of the scope for prevention. Sixty-nine authors from seventeen European countries, and from Canada and the USA have contributed to this volume, which is a truly international collaboration.

Myalgic encephalomyelitis. --- Chronic fatigue syndrome --- Diagnosis.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

CFS/ME is a debilitating disorder which affects both physical and psychological functioning. It is also a poorly understood condition which was not widely accepted as a specific disorder until only a few years ago. Cognitive Behaviour Therapy (CBT), in conjunction with other physical and medical therapies, is now generally accepted as the treatment of choice for people who are affected by CFS/ME. This book provides the perfect companion for patients to develop and apply new insights into overcoming some of their specific symptoms as well as coping with the syndrome, both during the course of their therapy and afterwards. It provides a helpful structure and framework for understanding CFS/ME and its effects as well as practical exercises to help address some of the symptoms that patients may experience.

Chronic fatigue syndrome --- Myalgic encephalomyelitis --- Cognitive therapy. --- Treatment.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Authors, Dutch --- Myalgic encephalomyelitis --- Chronic fatigue syndrome --- Biography. --- Patients --- -Chronic fatigue syndrome --- -Myalgic encephalomyelitis --- -#GSDBL --- Akureyri disease --- Benign myalgic encephalomyelitis --- Epidemic myalgic encephalomyelitis --- Epidemic neuromyasthenia --- Iceland disease --- Icelandic disease --- ME (Disease) --- Neuromyasthenia, Epidemic --- Post-viral fatigue syndrome --- Encephalomyelitis --- Myalgia --- Neuromuscular diseases --- Virus diseases --- Chronic fatigue and immune dysfunction syndrome --- Chronic fatigue immune dysfunction syndrome --- Diseases --- Fatigue --- Syndromes --- Epstein-Barr virus diseases --- Dutch authors --- Biography --- -Biography --- Dorrestein, Renate --- -Health --- -Dorrestein, Renate Maria --- Health --- Dutch literature --- Authors, Dutch - 20th century - Biography. --- Myalgic encephalomyelitis - Patients - Netherlands - Biography. --- Chronic fatigue syndrome - Patients - Netherlands - Biography.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Apheresis refers to an extracorporeal therapy which aims at removing pathological constituents from the patients’ blood. Due to the development of new techniques as well as the discovery of novel autoimmune antibodies, it is increasingly recognized as an important therapeutic option for a variety of autoimmune-mediated neurological disorders, including multiple sclerosis, myasthenia gravis, autoimmune encephalitis, Guillain–Barré syndrome, and many others. Therapeutic plasma exchange (TPE) constitutes the standard method of apheresis for most indications, while immunoadsorption (IA) offers a more specific, low-risk alternative. Both methods aim at removing auto-antibodies from the blood. Evidence for most neurological diseases is still low. Interestingly, more recent developments suggest that apheresis is not limited to the removal of autoantibodies but may also be useful in neurodegenerative and possibly even in acute vascular disorders.

Medicine --- immunoadsorption --- acute relapsing multiple sclerosis --- plasma exchange --- therapeutic apheresis --- multiple sclerosis --- optic neuritis --- relapse --- class IV --- steroids --- Alzheimer's clinical syndrome --- dementia --- autoantibodies --- α1-Adrenergic receptor --- Inflammatory neuropathy --- chronic inflammatory demyelinating polyneuropathy --- Guillain-Barré syndrome --- paranodal antibodies --- plasmapheresis --- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome --- ß2 adrenoreceptor autoantibody --- autoimmune encephalitis --- limbic encephalitis --- NMDAR (N-Methyl-D-Aspartat) --- antibody --- paraneoplastic --- apheresis --- therapeutic plasma exchange --- neurological diseases --- CRP --- stroke --- inflammation --- immunoadsorption --- acute relapsing multiple sclerosis --- plasma exchange --- therapeutic apheresis --- multiple sclerosis --- optic neuritis --- relapse --- class IV --- steroids --- Alzheimer's clinical syndrome --- dementia --- autoantibodies --- α1-Adrenergic receptor --- Inflammatory neuropathy --- chronic inflammatory demyelinating polyneuropathy --- Guillain-Barré syndrome --- paranodal antibodies --- plasmapheresis --- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome --- ß2 adrenoreceptor autoantibody --- autoimmune encephalitis --- limbic encephalitis --- NMDAR (N-Methyl-D-Aspartat) --- antibody --- paraneoplastic --- apheresis --- therapeutic plasma exchange --- neurological diseases --- CRP --- stroke --- inflammation